Gennex Laboratories Ltd

NSE: GENNEX · BSE: 531739 · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹9.99
Market cap: ₹242.7 Cr
Revenue (annual): ₹172.7 Cr
Net profit (annual): ₹20.98 Cr
P/E (TTM): 10.3×Sector 47.4×
Promoter holding: 23.63%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 5 Financial Results 3 Board Meeting Date 3 Other Announcement 2 Board Meeting Outcome 2 Share Pledge 1 Price Movement Clarification 1 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

14 Aug 2026 16:56 IST BSE

Financial Results

Gennex Laboratories Q1 FY27 Results: Net Profit ₹4.7 Cr, Down 6.0% YoY

Gennex Laboratories Ltd reported revenue from operations of ₹39.8 Cr (+16.4% YoY) and net profit of ₹4.7 Cr (-6.0% YoY) for Q1 FY27.

Key figure: Net profit ₹4.7 Cr · -6.0% YoY

Open full results → Read the filing ↗

30 May 2026 19:45 IST BSE

Financial Results

Gennex Laboratories Q4 FY26 Results: Net Profit ₹4.5 Cr, Up 45.2% YoY

Gennex Laboratories Ltd reported revenue from operations of ₹61 Cr (+51.4% YoY) and net profit of ₹4.5 Cr (+45.2% YoY) for Q4 FY26.

Key figure: Net profit ₹4.5 Cr · +45.2% YoY

Open full results → Read the filing ↗

30 May 2026 19:44 IST BSE

Financial Results

Gennex Laboratories Financial Results

Gennex Laboratories reported a consolidated total income of ₹180.99 Crore for FY26. The Board approved audited results despite a qualified opinion regarding unconfirmed asset and liability balances.

Value: ₹181.0 Cr

Read the filing ↗